Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Panobinostat/Velcade in Multiple Myeloma

This study has been terminated.
(This study was terminated because the drug company stopped making the study drug)
Information provided by (Responsible Party):
University of Arkansas Identifier:
First received: April 28, 2009
Last updated: February 20, 2015
Last verified: February 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2013
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)